Pinnacle Financial Partners (Tennessee)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,578
Closed -$318K 479
2021
Q3
$318K Buy
6,578
+66
+1% +$3.06K 0.01% 311
2021
Q2
$294K Buy
6,512
+228
+4% +$10.1K 0.01% 313
2021
Q1
$303K Sell
6,284
-1,799
-22% -$93.7K 0.01% 299
2020
Q4
$435K Hold
8,083
0.02% 265
2020
Q3
$298K Hold
8,083
0.02% 282
2020
Q2
$251K Hold
8,083
0.01% 297
2020
Q1
$223K Hold
8,083
0.02% 301
2019
Q4
$236K Buy
+8,083
New +$192K 0.01% 334

Other funds holding NEO

Pinnacle Financial Partners (Tennessee)'s NEO Position: Q4 2021 in Review

Pinnacle Financial Partners (Tennessee) sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 6,578 shares — an estimated $318K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in NEO in Q4 2019 and held it in 8 quarters. The position peaked at $435K in Q4 2020. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Pinnacle Financial Partners (Tennessee) reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 6,578 NeoGenomics shares in Q4 2021, an estimated $318K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in NeoGenomics in Q4 2019 and held it in 8 quarters.
  • Pinnacle Financial Partners (Tennessee)'s NeoGenomics position peaked at $435K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2021, filed 1 Feb 2022.